tirzepatide 5mg Yurpeak® Tirzepatide 5mg KwikPen -

Retatrutide is not available by prescription

2022 [cited 2024 Oct 14];7

That means there is no approved pharmaceutical version available through pharmacies, and the compound cannot be prescribed by physicians

Dysfunction in endothelial cells is characterized by a reduced ability to dilate blood vessels due to decreased availability of nitric oxide, dysregulated angiogenesis, increased inflammatory adhesion molecules, permeability, and low-density lipoprotein oxidation [28]

Observed RHR Increases in Clinical Data: + Liraglutide (1.8 mg daily): +610 bpm + Semaglutide (1.02.4 mg weekly): +24 bpm + Tirzepatide (515 mg weekly): +1.53.5 bpm + Exenatide (5-10 g Twice daily): +23 bpm A meta-analysis of over 60 randomized clinical trials found the mean RHR increase with GLP-1RAs to be 2.11 bpm (95% CI: 1.682.54)